GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » ROC (Joel Greenblatt) %
中文

Dolby Laboratories (Dolby Laboratories) ROC (Joel Greenblatt) % : 52.27% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Dolby Laboratories ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Dolby Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 52.27%.

The historical rank and industry rank for Dolby Laboratories's ROC (Joel Greenblatt) % or its related term are showing as below:

DLB' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 35.14   Med: 54.14   Max: 93.82
Current: 38.83

During the past 13 years, Dolby Laboratories's highest ROC (Joel Greenblatt) % was 93.82%. The lowest was 35.14%. And the median was 54.14%.

DLB's ROC (Joel Greenblatt) % is ranked better than
62.7% of 1067 companies
in the Business Services industry
Industry Median: 20.65 vs DLB: 38.83

Dolby Laboratories's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -0.70% per year.


Dolby Laboratories ROC (Joel Greenblatt) % Historical Data

The historical data trend for Dolby Laboratories's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories ROC (Joel Greenblatt) % Chart

Dolby Laboratories Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.72 40.95 54.55 35.14 45.49

Dolby Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.93 68.47 16.40 16.09 52.27

Competitive Comparison of Dolby Laboratories's ROC (Joel Greenblatt) %

For the Specialty Business Services subindustry, Dolby Laboratories's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolby Laboratories's ROC (Joel Greenblatt) % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Dolby Laboratories's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Dolby Laboratories's ROC (Joel Greenblatt) % falls into.



Dolby Laboratories ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(262.245 + 35.623 + 123.294) - (258.365 + 31.505 + 118.728)
=12.564

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(293.228 + 37.568 + 105.361) - (268.386 + 33.404 + 79.384)
=54.983

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Dolby Laboratories for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=289.248/( ( (521.78 + max(12.564, 0)) + (517.322 + max(54.983, 0)) )/ 2 )
=289.248/( ( 534.344 + 572.305 )/ 2 )
=289.248/553.3245
=52.27 %

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dolby Laboratories  (NYSE:DLB) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Dolby Laboratories ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dolby Laboratories (Dolby Laboratories) Business Description

Traded in Other Exchanges
Address
1275 Market Street, San Francisco, CA, USA, 94103-1410
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Executives
Kevin J Yeaman officer: VP, Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman officer: EVP, GEN. COUN. & SECRTY DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling officer: SVP, Entertainment C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton officer: SVP, Chief Marketing Officer 1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud director C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian director DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher director
Ryan Nicholson officer: VP, Corporate Controller C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar officer: SVP, Advanced Technology Group C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet director 9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park officer: SVP & Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay officer: Sr. Vice President, Research 1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew officer: EVP, Chief Financial Officer DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103